Regulatory Uncertainty in Life Sciences Is Increasing the Risk of Innovation
- Feb 18
- 1 min read
Innovation in life sciences has always involved uncertainty. Today, however, regulatory uncertainty is becoming a growing driver of risk, influencing not only approval pathways but also real world confidence in new therapies.
In his latest BioSpace opinion article, Ongoing Regulatory Uncertainty Means Innovation Is Now Higher Risk, Litmys Managing Partner Harris Kaplan explores how evolving regulatory expectations are reshaping development strategy and the likelihood that innovation succeeds beyond approval.
